Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder

Journal of Affective Disorders

Volumn 172, Issue , 2015, Pages 55-62

  Nunes, Sandra Odebrecht Vargas ^a,d   Piccoli De Melo, Luiz Gustavo ^a,d   Pizzo De Castro, Márcia Regina ^a,d   Barbosa, Décio Sabbatini ^a,d   Vargas, Heber Odebrecht ^a,d   Berk, Michael ^b,c   Maes, Michael ^a,b,d  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cardiovascular disease; Castelli risk index; Depression; Metabolic syndrome; Tobacco use disorder

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROGENIC COEFFICIENT; ATHEROGENIC INDEX OF PLASMA; BIPOLAR DISORDER; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC SYNDROME X; SEX DIFFERENCE; TOBACCO DEPENDENCE; TRIACYLGLYCEROL BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASES; METABOLISM; MIDDLE AGED; MOOD DISORDER; PLASMA; RISK FACTOR; TOBACCO USE DISORDER;

ADULT; ATHEROSCLEROSIS; BIPOLAR DISORDER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PLASMA; RISK FACTORS; SEX FACTORS; TOBACCO USE DISORDER; TRIGLYCERIDES;

EID: 84908428439     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.09.038     Document Type: Article

References (52)

1. Alberti, K.G., Zimmet, P., Shaw, J., 2005. The metabolic syndrome- a new worldwide definition. Lancet 366 (9491), 1059-1062.
2. Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P., Cleeman, J.I., Donato, K.A., Fruchart, J.C., James, W.P., Loria, C.M., Smith Jr., S.C., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (16), 1640-1645.
3. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Publishing, Arlington, VA p. 2000 (text revision).
4. Arumalla, V.K., Vani, N., Ramarao, J., 2011. Dose-dependent impacts on the diagnostic efficacies of atherogeniclipids in adult Indian smokers. JCDR 5, 1352-1355.
5. Bhagavath, P., 2012. Lipid profile and atherogenic index of plasma (AIP) in diabetic non smokers and smokers in coastal Karnataka. Int. J. A J Inst. Med. Sci. 1 (2), 93-97.
6. Bhardwaj, S., Bhattacharjee, J., Bhatnagar, M.K., Tyag, S., 2013. Atherogenic index of plasma, castelli risk index and atherogenic coefficient- new parameters in assessing cardiovascular risk. Int. J. Pharm Bio Sci. 3 (3), 354-364.
7. Batić-Mujanović, O., Zildzić, M., Beganlić, A., Kusljugić, Z., 2006. The effect of cigarette smoking on HDL-cholesterol level. Med. Arh. 60 (6), 90-92.
8. Berk, M., Williams, L.J., Jacka, F.N., O' Neil, A., Pasco, J.A., Moylan, S., Allen, N.B., Stuart, A.L., Hayley, A.C., Byrne, M.L., Maes, M., 2013. So depression is an inflammatory disease, but where the inflammation come from? BMC Med. 11, 200.
9. Bortolasci, C., Vargas, H.O.V., Souza-Nogueira, A., Barbosa, D.S., Moreira, S., Nunes, S.O.V., Berk, M., Dodd, S., Maes, M.., 2014. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J. Affect. Disord. 159, 23-30.
10. Brehm, A., Pfeiler, G., Pacini, G., Vierhapper, H., Roden, M., 2004. Relationship between serum lipoprotein ratios and insulin resistance in obesity. Clin. Chem. 50, 2316-2322.
11. Carney, R.M., Blumenthal, J.A., Freedland, K.E., Stein, P.K., Howells, W.B., Berkman, L.F., Watkins, L.L., Czajkowskj, S.M., Hayano, J., Domitrovich, P.P., Jaffe, A.S., 2005. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch. Intern. Med. 165 (13), 1486-1491.
12. Centers for Disease Control and Prevention (CDC), 2011. Quitting smoking among adults: United States, 2001-2010. Morb. Mortal. Wkly. Rep. 60 (44), 1513-1519.
13. Chelland Campbell, S., Moffatt, R.J., Stamford, B.A., 2008. Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 201 (2), 225-235.
14. Davis, C.E., Williams, D.H., Oganov, R.G., Tao, S.C., Rywik, S.L., Stein, Y., Little, J.A., 1996. Sex difference in high density lipoprotein cholesterol in six countries. Am. J. Epidemiol. 143 (11), 1100-1106.
15. Del Ben, C.M., Vilela, J.A.A., Crippa, J.A.S., Hallak, J.E.C., Labate, C.M., Zuardi, A.W., 2001. Reliability of the structured clinical interview for DSM-IV - clinical version translated into Portuguese. Rev. Bras. Psiquiatr. 23 (3), 156-159.
16. Di Matteo, M.R., Lepper, H.S., Croghan, T.W., 2000. Depression is a risk factor for noncompliance with medical treatment. Meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 160 (14), 2101-2107.
17. Dobiásová, M., Frohlich, J., 2000. The new atherogenic plasma index reflects thetriglyceride and HDL-cholesterol ratio, the lipoprotein particle size and thecholesterol esterification rate: changes during lipanor therapy. VnitrLek 46 (3), 152-156.
18. Dobiásová, M., Frohlich, J., 2001. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin. Biochem. 34 (7), 583-588.
19. Duivis, H., Jonge, P., Penninx, B., Na, B., Cohen, B., Whooley, M., 2011. Depressive symptoms, health behaviors, and subsequent Iinflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am. J. Psychiatry 168, 913-920.
20. Forey, B.A., Fry, J.S., Lee, P.N., Thornton, A.J., Coombs, K.J., 2013. The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes. Biomark. Res. 1 (1), 26.
21. Frasure-Smith, N., Lesperance, F., Julien, P., 2004. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry 55 (9), 891-896.
22. Fruchart, J.C., Nierman, M.C., Stroes, E.S., Kasteleinm, J.J., Duriez, P., 2004. New risk factors for atherosclerosis and patient risk assessment (III). Circulation 15109 (23 Suppl 1), S15-S19.
23. Gehi, A., Haas, D., Pipkin, S., Whooley, MA., 2005. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch. Intern. Med. 165 (21), 2508-2513.
24. Halaris, A., 2013. Inflammation, heart disease, and depression. Curr. Psychiatry Rep. 15 (10), 400.
25. Henrique, I.F.S., Micheli, D., Lacerda, R.B., Lacerda, L.A., Formigoni, M.L., 2004. Validation release screening test involvement with alcohol, cigarette and other substances (ASSIST). J. Braz. Med. Ass. 50 (2), 1-8.
26. Jacka, F.N., Sacks, G., Berk, M., Allender, S., 2014. Food policies for physical and mental health. BMC Psychiatry 14 (1), 132.
27. Kendler, K.S., Gardner, C.O., Fiske, A., Gatz, M., 2009. Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources ofcomorbidity. Arch. Gen. Psychiatry 66 (8), 857-863.
28. Lippi, G., Montagnana, M., Favaloro, E.J., Franchin,i, M., 2009. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin. Thromb. Hemost. 35 (3), 325-336.
29. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T., Murray, C., 2006. Global and regional burden of disease and risk factors: systematic analysis of population health data. Lancet 367, 1747-1757.
30. Maes, M., Ruckoanich, P., Chang, Y., Mahanonda, N., Berk, M., 2011a. Multiple aberrations in shared inflammatory and oxidative &nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD). Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2935 (3), 769-783.
31. Maes, M., Leonard, B., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C., Galecki, P., Berk, M., 2011b. Neuro) inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (3), 659-663.
32. Millán, J., Pintó, X., Muñoz, A., et al., 2009. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc. Health Risk Manag. 5, 757-765.
33. Moreno, R.A., Moreno, D.H., 1998. Hamilton and Montgomery & Asberg depression rating scales. Rev. Psiquiatr. Clin. 25 (5), 262-272.
34. Musselman, D., Evans, D.L., Nemeroff, C., 1998. The relationship of depression to cardiovascular disease. Epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55, 580-592.
35. Nunes, S.O.V., Vargas, H.O., Brum, J., Prado, E., Vargas, M.M., Castro, M.R.P., Dodd, S., Berk, M., 2012. A comparison of inflammatory markers in depressed and non depressed smokers. Nicotine Tob. Res. 14 (5), 540-546.
36. Nunes, S.O.V., Vargas, H.O., Prado, E., Barbosa, D.S., Melo, L.P., Moylan, S., Dodd, S., Berk, M., 2013a. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neurosci. Biobehav. Rev. 37 (8), 1336-1345.
37. Nunes, S.O.V., de Castro, M.R.P., Vargas, H.O., Vargas, M.M., Bueno, R.R.M., Fonseca, I.C.B., Dodd, S., Berk, M., 2013b. Clinical characteristics and smoking cessation: an analysis of sex and depressive disorders differences. Addict. Disord. Treat. 12 (3), 158-165.
38. Nunes, S.O.V., de Castro, M.R.P., Watanabe, M.A.E., Guembarovski, R.L., Vargas, H.O., Reiche, E.M.V., Morimoto, H.K., Dodd, S., Berk, M., 2014. Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence. Psychiatr. Genet. 24 (3), 87-93.
39. O'Neil, A., Sanna, L., Redlich, C., Sanderson, K., Jacka, F., Williams, L.J., Pasco, J.A., Berk, M., 2012. The impact of statins on psychological wellbeing: a systematic review and meta-analysis. BMC Med. 10, 154.
40. Otte, C., Marmar, C.R., Pipkin, S.S., Moos, R., Browner, W.S., Whooley, M.A., 2004. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: the Heart and Soul Study. Biol. Psychiatry 56 (4), 241-247 (PubMed: 15312811).
41. Schins, A., Hamulyak, K., Scharpe, S., Lousberg, R., Van Melle, J., Crijns, H., Honig, A., 2004. Whole blood serotonin and platelet activation indepressed postmyocardial infarction patients. Life Sci. 76 (6), 37-650.
42. Stafford, L., Berk, M., 2011. The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? J. Clin. Psychiatry 72 (9), 1229-1235.
43. Sun, K., Liu, J., Ning, G., 2012. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS One 7 (10), e47791.
44. Thelle, D.S., Førde, O.H., Arnesen, E., 1982. Distribution of high-density lipoprotein cholesterol according to age, sex, and ethnic origin: cardiovascular disease study in Finnmark 1977. J. Epidemiol. Community Health 36 (4), 243-247.
45. Vargas, H.O., Nunes, S.O.V., Castro, M.R.P., Vargas, M.M., Barbosa, D.S., Bortolasci, C.C., Venugapol, K., Dodd, S., Berk, M., 2013. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci. Lett. 544, 136-140.
46. Vargas, H.O., Nunes, S.O.V., Vargas, M.M., Barbosa, D.S., Vargas, M.M., Cestari, A., Dodd, S., Venugopal, K., Maes, M., Berk, M., 2014. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci. 102, 65-71.
47. Venkatesan, A., Hemalatha, A., Bobby, Z, Selvaraj, N., Sathiyapriya, V., 2006. Effect ofsmoking on lipid profile and lipid peroxidation in normal subjects. Indian J. Physiol. Pharmacol. 50 (3), 273-278.
48. Wang, Y., Zhao, X., O'Neil, A., Turner, A., Liu, X., Berk, M., 2013. Altered cardiac autonomic nervous function in depression. BMC Psychiatry 13 (1), 187.
49. Weissglas-Volkov, D., Pajukanta, P., 2010. Genetic causes of high and low serum HDL cholesterol. J. Lipid Res. 51, 2032-2057.
50. Whooley, M.A., 2006. Depression and cardiovascular disease: healing the broken-hearted. JAMA 295 (24), 2874-2881.
51. Whooley, M., de Jonge, P, Vittinghoff, E., Otte, C., Moos, R., Carney, R., Ali, S., Dowray, S., Na, B., Feldman, M., Schiller, N., Browner, W., 2008. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300 (20), 2379-2388.
52. Ziegelstein, R.C., Fauerbach, J.A., Stevens, S.S., Romanelli, J., Richter, D.P., Bush, D.E., 2000. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery frommyocardial infarction. Arch. Intern. Med. 160 (12), 1818-1823.